This Article Full Text Full Text (PDF) eLetters: Submit a response to this article Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article link to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nicolaides, C. Articles by Pavlidis, N. Search for Related Content PubMed PubMed Citation Articles by Nicolaides, C. Articles by Pavlidis, N.

Prognostic Factors in Aggressive Non-Hodgkin's Lymphomas

^a Oncology Department; ^b Pathology Department, Ioannina University Hospital, University of Ioannina, Ioannina, Greece

Correspondence: N. Pavlidis, M.D., Oncology Section, Department of Internal Medicine, University of Ioannina, Ioannina, 451 10 Greece. Telephone: 30-651-99394; Fax: 30-651-45944; e-mail: npavlid{at}cc.uoi.gr

Aggressive non-Hodgkin's lymphoma (NHL) is a biologically heterogeneous disease that can be cured with aggressive chemotherapy treatment. Different clinical, biological, cellular and molecular features have been identified as having prognostic significance on the outcome of NHL patients. The knowledge of these prognostic features can be used in everyday practice in order to predict the prognosis of every new NHL patient and tailor his or her treatment accordingly.

Key Words. Non-Hodgkin's lymphoma • Prognostic factors